Retinol-binding protein 4 (RBP4) is an adipocytokine associated with insulin resistance (IR). We tested serum levels of RBP4 to assess its link with steatosis in patients with genotype 1 chronic hepatitis C (CHC) or nonalcoholic fatty liver disease (NAFLD). Nondiabetic patients with CHC (n = 143) or
Retinol-binding protein 4 as a circulating marker of hepatic steatosis
β Scribed by Tetsuji Fujita
- Book ID
- 102240988
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 41 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
Tacke F, Wustefeld T, Horn R, Luedde T, Srinivas RA, Manns MP, et al. High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo. J Hepatol 2005;42:666-673. 7. Yagmur E, Trautwein C, Gressner AM, Tacke F. Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases. Am J Gastroenterol 2006;101:1244-1252. 8. Seo JA, Kim NH, Park SY, Kim HY, Ryu OH, Lee KW, et al. Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease. Clin Endocrinol (Oxf) 2008;68:555-560.
π SIMILAR VOLUMES
## Abstract Retinol is stored in liver, and the dynamic balance between its accumulation and mobilization is regulated by hepatic stellate cells (HSC). Representing less than 1% total liver protein, HSC can reach a very high intracellular retinoid (vitaminβA and its metabolites) concentration, whic
## Abstract We evaluated several markers to judge the postoperative state of protein nutriture in eight patients following surgery for cancer. Seven patients had a good prognosis and had no evidence of infections or other complications. Following surgery, all of the patients showed a shift toward a